Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Major Manufacturers Covered in This Report 1.3 Market Segment by Type 1.3.1 Global Leukemia Therapeutics Market Size Growth Rate by Type (2019-2025) 1.3.2 Gleevec 1.3.3 Sprycel 1.3.4 Tasigna 1.3.5 Clolar 1.3.6 Others 1.4 Market Segment by Application 1.4.1 Global Leukemia Therapeutics Market Share by Application (2019-2025) 1.4.2 Hospital 1.4.3 Clinic 1.5 Study Objectives 1.6 Years Considered 2 Global Growth Trends 2.1 Global Leukemia Therapeutics Market Size 2.1.1 Global Leukemia Therapeutics Revenue 2014-2025 2.1.2 Global Leukemia Therapeutics Sales 2014-2025 2.2 Leukemia Therapeutics Growth Rate by Regions 2.2.1 Global Leukemia Therapeutics Sales by Regions 2014-2019 2.2.2 Global Leukemia Therapeutics Revenue by Regions 2014-2019 2.3 Industry Trends 2.3.1 Market Top Trends 2.3.2 Market Drivers 3 Market Share by Manufacturers 3.1 Leukemia Therapeutics Sales by Manufacturers 3.1.1 Leukemia Therapeutics Sales by Manufacturers 2014-2019 3.1.2 Leukemia Therapeutics Sales Market Share by Manufacturers 2014-2019 3.2 Revenue by Manufacturers 3.2.1 Leukemia Therapeutics Revenue by Manufacturers (2014-2019) 3.2.2 Leukemia Therapeutics Revenue Share by Manufacturers (2014-2019) 3.2.3 Global Leukemia Therapeutics Market Concentration Ratio (CR5 and HHI) 3.3 Leukemia Therapeutics Price by Manufacturers 3.4 Key Manufacturers Leukemia Therapeutics Plants/Factories Distribution and Area Served 3.5 Date of Key Manufacturers Enter into Leukemia Therapeutics Market 3.6 Key Manufacturers Leukemia Therapeutics Product Offered 3.7 Mergers & Acquisitions, Expansion Plans 4 Market Size by Type 4.1 Sales and Revenue for Each Type 4.1.1 Gleevec Sales and Revenue (2014-2019) 4.1.2 Sprycel Sales and Revenue (2014-2019) 4.1.3 Tasigna Sales and Revenue (2014-2019) 4.1.4 Clolar Sales and Revenue (2014-2019) 4.1.5 Others Sales and Revenue (2014-2019) 4.2 Global Leukemia Therapeutics Sales Market Share by Type 4.3 Global Leukemia Therapeutics Revenue Market Share by Type 4.4 Leukemia Therapeutics Price by Type 5 Market Size by Application 5.1 Overview 5.2 Global Leukemia Therapeutics Sales by Application 6 United States 6.1 United States Leukemia Therapeutics Breakdown Data by Company 6.2 United States Leukemia Therapeutics Breakdown Data by Type 6.3 United States Leukemia Therapeutics Breakdown Data by Application 7 European Union 7.1 European Union Leukemia Therapeutics Breakdown Data by Company 7.2 European Union Leukemia Therapeutics Breakdown Data by Type 7.3 European Union Leukemia Therapeutics Breakdown Data by Application 8 China 8.1 China Leukemia Therapeutics Breakdown Data by Company 8.2 China Leukemia Therapeutics Breakdown Data by Type 8.3 China Leukemia Therapeutics Breakdown Data by Application 9 Rest of World 9.1 Rest of World Leukemia Therapeutics Breakdown Data by Company 9.2 Rest of World Leukemia Therapeutics Breakdown Data by Type 9.3 Rest of World Leukemia Therapeutics Breakdown Data by Application 9.4 Rest of World Leukemia Therapeutics Breakdown Data by Countries 9.4.1 Rest of World Leukemia Therapeutics Sales by Countries 9.4.2 Rest of World Leukemia Therapeutics Revenue by Countries 9.4.3 Japan 9.4.4 Korea 9.4.5 India 9.4.6 Southeast Asia 10 Company Profiles 10.1 Roche 10.1.1 Roche Company Details 10.1.2 Company Description and Business Overview 10.1.3 Sales, Revenue and Market Share of Leukemia Therapeutics 10.1.4 Leukemia Therapeutics Product Introduction 10.1.5 Roche Recent Development 10.2 GlaxoSmithKline 10.2.1 GlaxoSmithKline Company Details 10.2.2 Company Description and Business Overview 10.2.3 Sales, Revenue and Market Share of Leukemia Therapeutics 10.2.4 Leukemia Therapeutics Product Introduction 10.2.5 GlaxoSmithKline Recent Development 10.3 Novartis 10.3.1 Novartis Company Details 10.3.2 Company Description and Business Overview 10.3.3 Sales, Revenue and Market Share of Leukemia Therapeutics 10.3.4 Leukemia Therapeutics Product Introduction 10.3.5 Novartis Recent Development 10.4 Bristol-Myers Squibb 10.4.1 Bristol-Myers Squibb Company Details 10.4.2 Company Description and Business Overview 10.4.3 Sales, Revenue and Market Share of Leukemia Therapeutics 10.4.4 Leukemia Therapeutics Product Introduction 10.4.5 Bristol-Myers Squibb Recent Development 10.5 Eisai 10.5.1 Eisai Company Details 10.5.2 Company Description and Business Overview 10.5.3 Sales, Revenue and Market Share of Leukemia Therapeutics 10.5.4 Leukemia Therapeutics Product Introduction 10.5.5 Eisai Recent Development 10.6 Biogen Idec 10.6.1 Biogen Idec Company Details 10.6.2 Company Description and Business Overview 10.6.3 Sales, Revenue and Market Share of Leukemia Therapeutics 10.6.4 Leukemia Therapeutics Product Introduction 10.6.5 Biogen Idec Recent Development 10.7 ERYtech Pharma 10.7.1 ERYtech Pharma Company Details 10.7.2 Company Description and Business Overview 10.7.3 Sales, Revenue and Market Share of Leukemia Therapeutics 10.7.4 Leukemia Therapeutics Product Introduction 10.7.5 ERYtech Pharma Recent Development 10.8 Celgene 10.8.1 Celgene Company Details 10.8.2 Company Description and Business Overview 10.8.3 Sales, Revenue and Market Share of Leukemia Therapeutics 10.8.4 Leukemia Therapeutics Product Introduction 10.8.5 Celgene Recent Development 10.9 Genmab 10.9.1 Genmab Company Details 10.9.2 Company Description and Business Overview 10.9.3 Sales, Revenue and Market Share of Leukemia Therapeutics 10.9.4 Leukemia Therapeutics Product Introduction 10.9.5 Genmab Recent Development 10.10 Cephalon 10.10.1 Cephalon Company Details 10.10.2 Company Description and Business Overview 10.10.3 Sales, Revenue and Market Share of Leukemia Therapeutics 10.10.4 Leukemia Therapeutics Product Introduction 10.10.5 Cephalon Recent Development 10.11 Clavis Pharma 10.12 Pfizer 11 Value Chain and Sales Channels Analysis 11.1 Value Chain Analysis 11.2 Sales Channels Analysis 11.2.1 Leukemia Therapeutics Sales Channels 11.2.2 Leukemia Therapeutics Distributors 11.3 Leukemia Therapeutics Customers 12 Market Forecast 12.1 Global Leukemia Therapeutics Sales and Revenue Forecast 2019-2025 12.2 Global Leukemia Therapeutics Sales Forecast by Type 12.3 Global Leukemia Therapeutics Sales Forecast by Application 12.4 Leukemia Therapeutics Forecast by Regions 12.4.1 Global Leukemia Therapeutics Sales Forecast by Regions 2019-2025 12.4.2 Global Leukemia Therapeutics Revenue Forecast by Regions 2019-2025 12.5 United States Market Forecast 12.6 European Union Market Forecast 12.7 China Market Forecast 12.8 Rest of World 12.8.1 Japan 12.8.2 Korea 12.8.3 India 13 Research Findings and Conclusion 14 Appendix 14.1 Research Methodology 14.1.1 Methodology/Research Approach 14.1.1.1 Research Programs/Design 14.1.1.2 Market Size Estimation 14.1.1.3 Market Breakdown and Data Triangulation 14.1.2 Data Source 14.1.2.1 Secondary Sources 14.1.2.2 Primary Sources 14.2 Author Details 14.3 Disclaimer

List of Tables and Figures Figure Leukemia Therapeutics Product Picture Table Leukemia Therapeutics Key Market Segments Table Major Manufacturers Leukemia Therapeutics Covered in This Report Table Global Leukemia Therapeutics Market Size Growth Rate by Type 2019-2025 (K Units) & (Million US$) Figure Global Leukemia Therapeutics Sales Market Shar by Type 2014-2025 Figure Gleevec Figures Table Major Manufacturers of Gleevec Figure Sprycel Figures Table Major Manufacturers of Sprycel Figure Tasigna Figures Table Major Manufacturers of Tasigna Figure Clolar Figures Table Major Manufacturers of Clolar Figure Others Figures Table Major Manufacturers of Others Table Global Leukemia Therapeutics Market Share by Application 2019-2025 (K Units) Figure Hospital Use Case Figure Clinic Use Case Figure Leukemia Therapeutics Report Years Considered Figure Global Leukemia Therapeutics Market Size 2014-2025 (Million US$) Figure Global Leukemia Therapeutics Sales 2014-2019 (K Units) Table Global Leukemia Therapeutics Market Size by Regions 2014-2019 (K Units) & (Million US$) Table Global Leukemia Therapeutics Sales by Regions 2014-2019 (K Units) Table Global Leukemia Therapeutics Sales Market Share by Regions 2014-2019 Figure Global Leukemia Therapeutics Sales Market Share by Regions 2014-2019 Figure Global Leukemia Therapeutics Sales Market Share by Regions in 2019 Table Global Leukemia Therapeutics Revenue by Regions 2014-2019 (Million US$) Table Global Leukemia Therapeutics Revenue Market Share by Regions 2014-2019 Figure Global Leukemia Therapeutics Revenue Market Share by Regions 2014-2019 Figure Global Leukemia Therapeutics Revenue Market Share by Regions in 2019 Table Market Top Trends Table Global Leukemia Therapeutics Sales by Manufacturers (2014-2019) (K Units) Table Global Leukemia Therapeutics Sales Share by Manufacturers (2014-2019) Figure Global Leukemia Therapeutics Sales Share by Manufacturers in 2019 Table Leukemia Therapeutics Revenue by Manufacturers (2014-2019) (Million USD) Table Leukemia Therapeutics Revenue Share by Manufacturers (2014-2019) Figure Leukemia Therapeutics Value Share by Manufacturers in 2019 Table Global Leukemia Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI) Table Key Manufacturers Leukemia Therapeutics Price (2014-2019) (USD/Unit) Table Key Manufacturers Leukemia Therapeutics Plants/Factories Distribution Table Key Manufacturers Leukemia Therapeutics Area Served Table Date of Key Manufacturers Enter into Leukemia Therapeutics Market Table Key Manufacturers Leukemia Therapeutics Product Type Table Mergers & Acquisitions, Expansion Plans Table Global Gleevec Sales and Revenue (2014-2019) (K Units) & (Million US$) Table Global Sprycel Sales and Revenue (2014-2019) (K Units) & (Million US$) Table Global Tasigna Sales and Revenue (2014-2019) (K Units) & (Million US$) Table Global Clolar Sales and Revenue (2014-2019) (K Units) & (Million US$) Table Global Others Sales and Revenue (2014-2019) (K Units) & (Million US$) Table Global Leukemia Therapeutics Sales by Type (2014-2019) (K Units) Table Global Leukemia Therapeutics Sales Share by Type (2014-2019) Figure Global Leukemia Therapeutics Sales Market Share by Type (2014-2019) Figure Global Leukemia Therapeutics Sales Market Share by Type in 2018 Table Global Leukemia Therapeutics Revenue by Type (2014-2019) (Million US$) Table Global Leukemia Therapeutics Revenue Share by Type (2014-2019) Figure Global Leukemia Therapeutics Revenue Market Share by Type (2014-2019) Figure Global Leukemia Therapeutics Revenue Market Share by Type in 2018 Table Leukemia Therapeutics Price by Type 2014-2019 (USD/Unit) Table Global Leukemia Therapeutics Sales by Application (2014-2019) (K Units) Table Global Leukemia Therapeutics Sales Share by Application (2014-2019) Figure Global Sales Leukemia Therapeutics Market Share by Application (2014-2019) Figure Global Sales Leukemia Therapeutics Market Share by Application (2014-2019) Figure United States Leukemia Therapeutics Sales Growth Rate 2014-2019 (K Units) Figure United States Leukemia Therapeutics Revenue Growth Rate 2014-2019 (Million US$) Table United States Leukemia Therapeutics Sales by Company (2014-2019) (K Units) Table United States Leukemia Therapeutics Sales Market Share by Company (2014-2019) Figure United States Leukemia Therapeutics Sales Market Share by Company in 2019 Table United States Leukemia Therapeutics Sales by Type (2014-2019) (K Units) Table United States Leukemia Therapeutics Sales Market Share by Type (2014-2019) Figure United States Leukemia Therapeutics Market Share by Type in 2019 Table United States Leukemia Therapeutics Sales by Application (2014-2019) (K Units) Table United States Leukemia Therapeutics Sales Market Share by Application (2014-2019) Figure United States Leukemia Therapeutics Market Share by Application in 2019 Figure European Union Leukemia Therapeutics Sales Growth Rate 2014-2019 (K Units) Figure European Union Leukemia Therapeutics Revenue Growth Rate 2014-2019 (Million US$) Table European Union Leukemia Therapeutics Sales by Company (2014-2019) (K Units) Table European Union Leukemia Therapeutics Sales Market Share by Company (2014-2019) Figure European Union Leukemia Therapeutics Sales Market Share by Company in 2019 Table European Union Leukemia Therapeutics Sales by Type (2014-2019) (K Units) Table European Union Leukemia Therapeutics Sales Market Share by Type (2014-2019) Figure 2018 European Union Leukemia Therapeutics Market Share by Type Table European Union Leukemia Therapeutics Sales by Application (2014-2019) (K Units) Table European Union Leukemia Therapeutics Sales Market Share by Application (2014-2019) Figure 2018 European Union Leukemia Therapeutics Market Share by Application Figure China Leukemia Therapeutics Sales Growth Rate 2014-2019 (K Units) Figure China Leukemia Therapeutics Revenue Growth Rate 2014-2019 (Million US$) Table China Leukemia Therapeutics Sales by Company (2014-2019) (K Units) Table China Leukemia Therapeutics Sales Market Share by Company (2014-2019) Figure China Leukemia Therapeutics Sales Market Share by Company in 2019 Table China Leukemia Therapeutics Sales by Type (2014-2019) (K Units) Table China Leukemia Therapeutics Sales Market Share by Type (2014-2019) Figure China Leukemia Therapeutics Market Share by Type in 2019 Table China Leukemia Therapeutics Sales by Application (2014-2019) (K Units) Table China Leukemia Therapeutics Sales Market Share by Application (2014-2019) Figure China Leukemia Therapeutics Market Share by Application in 2019 Figure Rest of World Leukemia Therapeutics Sales Growth Rate 2014-2019 (K Units) Figure Rest of World Leukemia Therapeutics Revenue Growth Rate 2014-2019 (Million US$) Table Rest of World Leukemia Therapeutics Sales by Company (2014-2019) (K Units) Table Rest of World Leukemia Therapeutics Sales Market Share by Company (2014-2019) Figure Rest of World Leukemia Therapeutics Sales Market Share by Company in 2019 Table Rest of World Leukemia Therapeutics Sales by Type (2014-2019) (K Units) Table Rest of World Leukemia Therapeutics Sales Market Share by Type (2014-2019) Figure Rest of World Leukemia Therapeutics Market Share by Type in 2019 Table Rest of World Leukemia Therapeutics Sales by Application (2014-2019) (K Units) Table Rest of World Leukemia Therapeutics Sales Market Share by Application (2014-2019) Figure Rest of World Leukemia Therapeutics Market Share by Application in 2019 Table Rest of World Leukemia Therapeutics Sales by Countries (2014-2019) (K Units) Table Rest of World Leukemia Therapeutics Sales Market Share by Countries (2014-2019) Figure Rest of World Leukemia Therapeutics Sales Market Share by Countries in 2019 Table Rest of World Leukemia Therapeutics Revenue by Countries (2014-2019) (Million US$) Table Rest of World Leukemia Therapeutics Revenue Market Share by Countries (2014-2019) Figure Rest of World Leukemia Therapeutics Revenue Market Share by Countries in 2019 Figure Japan Leukemia Therapeutics Sales Growth Rate (2014-2019) (K Units) Figure Japan Leukemia Therapeutics Revenue Growth Rate (2014-2019) (K Units) Figure Korea Leukemia Therapeutics Sales Growth Rate (2014-2019) (K Units) Figure Korea Leukemia Therapeutics Revenue Growth Rate (2014-2019) (K Units) Figure India Leukemia Therapeutics Sales Growth Rate (2014-2019) (K Units) Figure India Leukemia Therapeutics Revenue Growth Rate (2014-2019) (K Units) Figure Southeast Asia Leukemia Therapeutics Sales Growth Rate (2014-2019) (K Units) Figure Southeast Asia Leukemia Therapeutics Revenue Growth Rate (2014-2019) (K Units) Table Roche Company Details Table Roche Description and Business Overview Table Roche Leukemia Therapeutics Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019) Table Roche Leukemia Therapeutics Sales Growth Rate (2014-2019) Table Roche Leukemia Therapeutics Sales Market Share in Global Market Table Roche Recent Development Table GlaxoSmithKline Company Details Table GlaxoSmithKline Description and Business Overview Table GlaxoSmithKline Leukemia Therapeutics Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019) Table GlaxoSmithKline Leukemia Therapeutics Sales Growth Rate (2014-2019) Table GlaxoSmithKline Leukemia Therapeutics Sales Market Share in Global Market Table GlaxoSmithKline Recent Development Table Novartis Company Details Table Novartis Description and Business Overview Table Novartis Leukemia Therapeutics Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019) Table Novartis Leukemia Therapeutics Sales Growth Rate (2014-2019) Table Novartis Leukemia Therapeutics Sales Market Share in Global Market Table Novartis Recent Development Table Bristol-Myers Squibb Company Details Table Bristol-Myers Squibb Description and Business Overview Table Bristol-Myers Squibb Leukemia Therapeutics Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019) Table Bristol-Myers Squibb Leukemia Therapeutics Sales Growth Rate (2014-2019) Table Bristol-Myers Squibb Leukemia Therapeutics Sales Market Share in Global Market Table Bristol-Myers Squibb Recent Development Table Eisai Company Details Table Eisai Description and Business Overview Table Eisai Leukemia Therapeutics Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019) Table Eisai Leukemia Therapeutics Sales Growth Rate (2014-2019) Table Eisai Leukemia Therapeutics Sales Market Share in Global Market Table Eisai Recent Development Table Biogen Idec Company Details Table Biogen Idec Description and Business Overview Table Biogen Idec Leukemia Therapeutics Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019) Table Biogen Idec Leukemia Therapeutics Sales Growth Rate (2014-2019) Table Biogen Idec Leukemia Therapeutics Sales Market Share in Global Market Table Biogen Idec Recent Development Table ERYtech Pharma Company Details Table ERYtech Pharma Description and Business Overview Table ERYtech Pharma Leukemia Therapeutics Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019) Table ERYtech Pharma Leukemia Therapeutics Sales Growth Rate (2014-2019) Table ERYtech Pharma Leukemia Therapeutics Sales Market Share in Global Market Table ERYtech Pharma Recent Development Table Celgene Company Details Table Celgene Description and Business Overview Table Celgene Leukemia Therapeutics Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019) Table Celgene Leukemia Therapeutics Sales Growth Rate (2014-2019) Table Celgene Leukemia Therapeutics Sales Market Share in Global Market Table Celgene Recent Development Table Genmab Company Details Table Genmab Description and Business Overview Table Genmab Leukemia Therapeutics Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019) Table Genmab Leukemia Therapeutics Sales Growth Rate (2014-2019) Table Genmab Leukemia Therapeutics Sales Market Share in Global Market Table Genmab Recent Development Table Cephalon Company Details Table Cephalon Description and Business Overview Table Cephalon Leukemia Therapeutics Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019) Table Cephalon Leukemia Therapeutics Sales Growth Rate (2014-2019) Table Cephalon Leukemia Therapeutics Sales Market Share in Global Market Table Cephalon Recent Development Table Clavis Pharma Company Details Table Pfizer Company Details Figure Leukemia Therapeutics Value Chain Table Leukemia Therapeutics Distributors List Table Leukemia Therapeutics Customers List Table Global Leukemia Therapeutics Sales Forecast 2019-2025 (K Units) & (Million US$) Figure Global Leukemia Therapeutics Sales Forecast 2019-2025 (K Units) Figure Global Leukemia Therapeutics Revenue Forecast 2019-2025 (Million US$) Table Global Leukemia Therapeutics Sales Forecast by Type 2019-2025 (K Units) Figure Global Leukemia Therapeutics Sales Forecast by Type 2019-2025 (K Units) Figure Global Leukemia Therapeutics Sales Market Share Forecast by Type 2019-2025 Table Global Leukemia Therapeutics Sales Forecast by Application 2019-2025 (K Units) Figure Global Leukemia Therapeutics Sales Forecast by Application 2019-2025 (K Units) Figure Global Leukemia Therapeutics Sales Market Share Forecast by Application 2019-2025 Table Global Leukemia Therapeutics Sales Forecast by Regions 2019-2025 (K Units) Figure Global Leukemia Therapeutics Sales Forecast by Regions 2019-2025 (K Units) Figure Global Leukemia Therapeutics Sales Market Share Forecast by Regions 2019-2025 Table Global Leukemia Therapeutics Revenue Forecast by Regions 2019-2025 (K Units) Figure Global Leukemia Therapeutics Revenue Forecast by Regions 2019-2025 (K Units) Figure Global Leukemia Therapeutics Revenue Market Share Forecast by Regions 2019-2025 Figure United States Leukemia Therapeutics Sales Forecast 2019-2025 (K Units) Figure United States Leukemia Therapeutics Revenue Forecast 2019-2025 (Million US$) Figure European Union Leukemia Therapeutics Sales Forecast 2019-2025 (K Units) Figure European Union Leukemia Therapeutics Revenue Forecast 2019-2025 (Million US$) Figure China Leukemia Therapeutics Sales Forecast 2019-2025 (K Units) Figure China Leukemia Therapeutics Revenue Forecast 2019-2025 (Million US$) Figure Japan Leukemia Therapeutics Sales Forecast 2019-2025 (K Units) Figure Japan Leukemia Therapeutics Revenue Forecast 2019-2025 (Million US$) Figure Korea Leukemia Therapeutics Sales Forecast 2019-2025 (K Units) Figure Korea Leukemia Therapeutics Revenue Forecast 2019-2025 (Million US$) Figure India Leukemia Therapeutics Sales Forecast 2019-2025 (K Units) Figure India Leukemia Therapeutics Revenue Forecast 2019-2025 (Million US$) Figure Southeast Asia Leukemia Therapeutics Sales Forecast 2019-2025 (K Units) Figure Southeast Asia Leukemia Therapeutics Revenue Forecast 2019-2025 (Million US$) Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources